Registered entities
Veloxis Pharmaceuticals, Inc
Reg. No. 20151525491United States
Veloxis Pharmaceuticals A/s
Reg. No. 26527767Denmark
Social engagement
Social engagement: 14.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Private equity | 3 | 50% |
| Other / undisclosed | 1 | 17% |
Recent activity
22 Jun 2026
Event
ATC2026Boston
7 May 2026
Event
National Kidney Foundation Spring Clinical Meeting
22 Apr 2026
Milestone
regulatory
